Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Acute Covid-19 Vaccination Syndrome”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06967428
What this trial is testing

Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

Who this might be right for
Vaccine Adverse ReactionPost Acute Covid-19 Vaccination Syndrome
Independent Medical Alliance 100
Not applicableUnknownNCT05484700
What this trial is testing

Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms

Who this might be right for
Long COVID-19
Mahidol University 305
Not applicableStudy completedNCT05894590
What this trial is testing

Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,680
Not applicableUnknownNCT06105346
What this trial is testing

Prevalence of ENT Diseseas

Who this might be right for
ConscriptsMilitary Induction BoardENT Disease+6 more
Medical University of Graz 10,000
Testing effectiveness (Phase 2)Study completedNCT05077254
What this trial is testing

COVID Protection After Transplant-Immunosuppression Reduction

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Post-approval studies (Phase 4)UnknownNCT05232292
What this trial is testing

Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure

Who this might be right for
Acute Coronary SyndromeChronic Heart Failure
Samara Regional Cardiology Dispensary 200
Not applicableLooking for participantsNCT07400848
What this trial is testing

Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome

Who this might be right for
Post-Acute COVID-19 Vaccination SyndromePostviral Fatigue
University of Bern 200
Not applicableNot Yet RecruitingNCT06992401
What this trial is testing

Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism

Who this might be right for
Post-Acute Sequelae of SARS-CoV-2 InfectionLong COVIDLong COVID Fatigue+3 more
Tamara C Tamas 50
Not applicableUnknownNCT05587868
What this trial is testing

COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients

Who this might be right for
COVID-19SARS CoV-2 Infection
Indonesia University 250
Not applicableStudy completedNCT06452082
What this trial is testing

Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl

Who this might be right for
Vitamin d DeficiencyCOVID-19Long COVID
IRCCS San Raffaele 200
Not applicableStudy completedNCT05894525
What this trial is testing

Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 8,844
Not applicableStudy completedNCT04841785
What this trial is testing

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Who this might be right for
Covid19SARS-CoV InfectionChronic Kidney Diseases
University Medical Center Groningen 4,868